What is the main business of Fort-Med?

The main business activity of Fort-Med focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 26, 2010.

Where is the headquarters located?

The headquarters is located at: Obrońców Tobruku 29, 01-494 Warszawa.

What is the share capital?

The share capital of the company is PLN 200,000 (approx. $54,025).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

What was the revenue?

In 2023, the company generated total revenue of $307,447, representing an increase of 1.6% compared to 2022.

Is the company profitable?

Yes, in 2023 the company was profitable, achieving a net profit of $8,630, meaning the company increased its profit by 8.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $60,975 in 2023, representing 20% of all operating expenses.

Fort-Medsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2010-02-26

Share capital

200,000.00 PLN

Registered address

Obrońców Tobruku 29/177, 01-494 Warszawa, Poland

Electronic delivery address

AE:PL-64046-69013-RSCUV-23

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 4 of 5 financial statements were filed late (the longest delay 1258 days for 2020).

2024not filed
202326/03/2025
202226/03/2025
202126/03/2025
202026/03/2025
201922/07/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 307.45kMedianUSD 1.92mAverageUSD 5.20m

Net profit

This companyUSD 8.63kMedianUSD 20.66kAverageUSD 86.62k

Operating costs

This companyUSD 297.96kMedianUSD 1.88mAverageUSD 5.04m

Assets

This companyUSD 81.18kMedianUSD 544.32kAverageUSD 1.76m

Industry

Authorized Representatives

Marek Andrzej Łapiński – Vice President of the Management Board

Iwona Barbara Łapińska – President of the Management Board

Manner of representation

The company is represented, declarations are made and documents are signed on behalf of the company by each member of the management board acting independently.

Ownership

Owner	Shares	Share value	Stake
Iwona Barbara Łapińskaage 56	2,000	$27,012.43	50%
Marek Andrzej Łapińskiage 62	2,000	$27,012.43	50%

Iwona Barbara Łapińska and Marek Andrzej Łapiński hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2013-12-01.

Alior Bank
88 2490 0005 0000 4520 7937 4408

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Cosmedicasp. z o.o.	$49,355,260.75	cosmedica.pl
DR ZdrowieS.A.	$40,415,498.47	drzdrowie.pl
MagmaxS.A.	$4,200,912.15	magmaxsa.pl
Novopharm - Millersp. j.	$2,839,228.36	apteka.zyj-zdrowo.com
MaglowS.A.	$1,356,219.12	maglow.pl
Farmacja Im. O. Klimuszkisp. z o.o.	$1,289,548.20	zyj-zdrowo.com
Nukloversp. z o.o.	$227,479.26	nuklover.com
Massmedsp. z o.o.	$49,747.70	mojoapps.co
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.	$2,740.83	kwendasa.pl
Femaherbsp. z o.o.	$655.76	femaherb.com

Change history

Date	Event
2020-09-10	PKD change (Removed: 86.21.Z, 86.22.Z, 86.90.C, 86.90.E)
2010-02-26	Entered in the register

FAQ

Last updated: 2026-04-18